These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38962322)

  • 21. Effect of ceftazidime-avibactam combined with different antimicrobials against carbapenem-resistant
    Wu Y; Yu W; Chu X; Zhang J; Jia P; Liu X; Zhu Y; Xu Y; Yang Q
    Microbiol Spectr; 2024 Jun; 12(6):e0010724. PubMed ID: 38712934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal Genomic Characterization of Carbapenemase-producing Enterobacteriaceae (CPE) Reveals Changing Pattern of CPE Isolated in Hong Kong Hospitals.
    Zhu C; Li C; Lai CKC; Ng R; Chau KY; Wong KT; Lo NWS; Barua N; Yang Y; Liyanapathirana V; Hui M; Lai RW; Fung KSC; Tsang DN; Ip M
    Int J Antimicrob Agents; 2021 Nov; 58(5):106430. PubMed ID: 34525401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole genome sequencing characterization of Slovenian carbapenem-resistant Klebsiella pneumoniae, including OXA-48 and NDM-1 producing outbreak isolates.
    Benulič K; Pirš M; Couto N; Chlebowicz M; Rossen JWA; Zorec TM; Seme K; Poljak M; Lejko Zupanc T; Ružić-Sabljić E; Cerar T
    PLoS One; 2020; 15(4):e0231503. PubMed ID: 32282829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Two Distinct Subpopulations of Klebsiella pneumoniae ST16 Co-Occurring in a Single Patient.
    Zhang B; Hu R; Liang Q; Liang S; Li Q; Bai J; Ding M; Zhang F; Zhou Y
    Microbiol Spectr; 2022 Jun; 10(3):e0262421. PubMed ID: 35467408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spread of Plasmid-Encoded NDM-1 and GES-5 Carbapenemases among Extensively Drug-Resistant and Pandrug-Resistant Clinical Enterobacteriaceae in Durban, South Africa.
    Pedersen T; Sekyere JO; Govinden U; Moodley K; Sivertsen A; Samuelsen Ø; Essack SY; Sundsfjord A
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29507063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Potential Use of Ceftazidime-Avibactam Against Carbapenem Resistant
    Nasomsong W; Nulsopapon P; Changpradub D; Pongchaidecha M; Pungcharoenkijkul S; Juntanawiwat P; Simsiriporn W; Santimaleeworagun W
    Drug Des Devel Ther; 2021; 15():3095-3104. PubMed ID: 34295150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China.
    Zhang P; Shi Q; Hu H; Hong B; Wu X; Du X; Akova M; Yu Y
    Clin Microbiol Infect; 2020 Jan; 26(1):124.e1-124.e4. PubMed ID: 31494252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae Coharboring a
    Ahmed MAEE; Yang Y; Yang Y; Yan B; Chen G; Hassan RM; Zhong LL; Chen Y; Roberts AP; Wu Y; He R; Liang X; Qin M; Dai M; Zhang L; Li H; Yang F; Xu L; Tian GB
    mSphere; 2021 May; 6(3):. PubMed ID: 34011682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clone dissemination of IncX3 plasmid carrying bla
    Huo T; Kong Z; Dong G; Zhao S; Liu X; Jiang F
    J Glob Antimicrob Resist; 2024 Mar; 36():244-251. PubMed ID: 38272211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms and fitness of ceftazidime/avibactam-resistant Klebsiella pneumoniae clinical strains in Taiwan.
    Chou SH; Chuang C; Juan CH; Ho YC; Liu SY; Chen L; Lin YT
    Int J Antimicrob Agents; 2024 Aug; 64(2):107244. PubMed ID: 38925227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of a clinical Salmonella enterica serovar 1,4,[5], 12: i:-isolate, ST3606, in China with susceptibility decrease to ceftazidime-avibactam carrying a novel bla
    Wei J; Shen S; Zhang Q; Lu J; Mao S; Zou C; Zhou H; Wei Y; Ou X; Huang J; Wang D; Li X; Wan Q; Shan B; Zhang Z
    Eur J Clin Microbiol Infect Dis; 2024 May; 43(5):829-840. PubMed ID: 38388738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unveiling the genetic architecture and transmission dynamics of a novel multidrug-resistant plasmid harboring bla
    Han D; Ma S; He C; Yang Y; Li P; Lu L
    BMC Microbiol; 2024 May; 24(1):178. PubMed ID: 38783210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Characteristics of an NDM-4 and OXA-181 Co-Producing K51-ST16 Carbapenem-Resistant Klebsiella pneumoniae: Study of Its Potential Dissemination Mediated by Conjugative Plasmids and Insertion Sequences.
    Zhang F; Li Z; Liu X; Luo G; Wu Y; Li C; Zhao J; Zhang Y; Hu Y; Lu B
    Antimicrob Agents Chemother; 2023 Jan; 67(1):e0135422. PubMed ID: 36602346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spread and evolution of bla
    Yang W; Tang C; Shen S; Shi Q; Hu F
    Int J Antimicrob Agents; 2024 May; 63(5):107149. PubMed ID: 38508537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization of novel sequence type of carbapenem-resistant New Delhi metallo-β-lactamase-1-producing Klebsiella pneumoniae in the neonatal intensive care unit of an Indian hospital.
    Ahmad N; Ali SM; Khan AU
    Int J Antimicrob Agents; 2019 Apr; 53(4):525-529. PubMed ID: 30578964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of KPC Variant and Porin Genotype on the
    Wilson WR; Kline EG; Jones CE; Morder KT; Mettus RT; Doi Y; Nguyen MH; Clancy CJ; Shields RK
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Klebsiella pneumoniae carbapenemase (KPC) in urinary infection isolates.
    Bedenić B; Sardelić S; Bogdanić M; Zarfel G; Beader N; Šuto S; Krilanović M; Vraneš J
    Arch Microbiol; 2021 May; 203(4):1825-1831. PubMed ID: 33507339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceftazidime-avibactam resistance determination in carbapenem-resistant Klebsiella pneumoniae infections before its use in practice.
    Eren-Kutsoylu OÖ; Ceylan-Çimendağ H; Sari-Kaygisiz AN; Tanriverdi ES; Özbek ÖA; Öktem IMA; Otlu B; Avkan-Oğuz V
    J Infect Dev Ctries; 2024 Jul; 18(7):1020-1025. PubMed ID: 39078779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying Spectra of Activity and Therapeutic Niches for Ceftazidime-Avibactam and Imipenem-Relebactam against Carbapenem-Resistant Enterobacteriaceae.
    Haidar G; Clancy CJ; Chen L; Samanta P; Shields RK; Kreiswirth BN; Nguyen MH
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of Ceftazidime-Avibactam and its comparators against Carbapenem resistant Enterobacterales collected across India: results from ATLAS surveillance 2018 to 2019.
    Bakthavatchalam YD; Routray A; Mane A; Kamat S; Gupta A; Bari AK; Rohit A; Poojary A; Mukherjee DN; Sethuraman N; Munshi N; Shah S; Balaji V; Gupta Y
    Diagn Microbiol Infect Dis; 2022 May; 103(1):115652. PubMed ID: 35255290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.